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The glycoproteins gH and gL of human cytomegalovirus (HCMV) form a complex either with
pUL74 (trimeric complex) or with proteins of the UL128 locus (pentameric complex). While the
pentameric complex is dispensable for viral growth in fibroblasts, deletion of pUL74 causes a
small plaque phenotype in HCMV lab strains, accompanied by greatly reduced cell-free
infectivity. As HCMV isolates, shortly after cultivation from clinical specimens, do not release cell-
free infectious viruses, we wondered whether deletion of pUL74 would also affect virus growth in
this background. To address this question, we took advantage of the bacterial artificial
chromosome (BAC)-cloned virus Merlin-RL13tetO, which grows cell associated due to the
inducible expression of the viral RL13 gene, thereby resembling clinical isolates. Stop codons
were introduced by seamless mutagenesis into UL74 and/or the UL128 locus to prevent
expression of the trimeric or pentameric complex, respectively. Virus mutants were reconstituted
by transfection of the respective genomes into cultured cells and analysed with respect to focal
growth. When the UL128 locus was intact, deletion of pUL74 did not notably affect focal growth
of Merlin, irrespective of RL13 expression. In the absence of UL128 expression, foci were
increased compared with wild-type, and infectious cell-free virus was produced. Under these
conditions, disruption of UL74 completely prevented virus spread from initially transfected cells to
surrounding cells. In conclusion the contribution of pUL74 is masked when the UL128 locus is
expressed at high levels, and its role in cell-free virus spread is only revealed when expression of
the pentameric complex is inhibited.
INTRODUCTION
All herpesviruses depend on complexes of glycoproteins H
and L for successful replication, but they vary with respect
to the composition of these complexes (Connolly et al.,
2011; Eisenberg et al., 2012). While many herpesviruses
only form gH/gL heterodimers, betaherpesviruses encode a
third complex member, glycoprotein O, resulting in the
formation of a gH/gL/gO heterotrimer. In human cyto-
megalovirus (HCMV) gO is encoded by the UL74 reading
frame (Huber & Compton, 1997, 1998; Li et al., 1997), and
disruption of the respective protein pUL74 is associated
with a reduction in cell-free infectivity and plaque size
(Dunn et al., 2003; Hobom et al., 2000; Jiang et al., 2008;
Wille et al., 2010; Yu et al., 2003). In addition, gH and gL
can form a pentameric complex with the three proteins
encoded by the UL128 gene locus, and disruption of this
complex restricts the cell tropism of the virus, greatly
reducing infection efficiency of epithelial cells, endothelial
cells and leukocytes (Adler et al., 2006; Hahn et al., 2004;
Ryckman et al., 2008b; Wang & Shenk 2005).
Supported by interference studies, it was assumed that
the trimeric and the pentameric gH/gL complex serve the
same function on different cell types, e.g. triggering the
proprietary fusion protein gB upon binding to the respect-
ive receptor (Ryckman et al., 2008a; Vanarsdall et al., 2011,
2012). However, a recent comparison of cell-free virions
Three supplementary figures are available with the online Supplementary
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with different levels of gH/gL complexes in their envelopes
strongly suggests that the trimeric complex mediates effi-
cient entry of cell-free virus irrespective of the cell type by
promoting the fusion step, whereas the pentameric complex
might serve a distinct additional function required only on
certain cell types such as endothelial or epithelial cells
(Zhou et al., 2015). This is concordant with the notion that
deletion of gO reduces cell-free infectivity not only on
fibroblasts but also on endothelial and epithelial cells (Jiang
et al., 2008; Wille et al., 2010).
While the contribution of gH/gL complexes during the
entry of cell-free HCMV is well documented, little data
are available regarding their role during cell-associated
transmission. To date, accessory proteins have only been
knocked out in the genetic background of strains that
release cell-free infectious progeny. Under these condi-
tions it is hard to distinguish between effects on cell-free
transmission and effects on cell-associated spread.
A differentiation between the two transmission modes
matters as clinical isolates grow cell-associated in cell cul-
ture after primary isolation from patient material (Sinzger
et al., 1999), and cell-to-cell spread is, hence, regarded as a
relevant means of HCMV dissemination in vivo. With con-
tinuous passaging of HCMV isolates, disrupting mutations
in RL13 and the UL128 locus emerge, leading to release of
cell-free infectivity (Dargan et al., 2010). These alterations
occur within a few passages and obviously provide a strong
growth advantage as it is impossible to reconstitute and
maintain a genetically complete virus in cell culture unless
both gene regions are protected against this selective pres-
sure by conditional repression (Dargan et al., 2010; Stanton
et al., 2010).
We used a genetically complete HCMV, generated using the
bacterial artificial chromosome (BAC)-cloned strain Mer-
lin, to revisit the role of accessory proteins of the gH/
gL complex in the presence of an intact RL13 gene. Remark-
ably, in a recent in vivo study the UL74 homologue of the
murine cytomegalovirus, m74, was required only for the
initial cell-free infection of organs but was dispensable for
the subsequent focal spread within the tissues of infected
organs (Lemmermann et al., 2015). This finding further
emphasizes the importance of analysing the role of these
complexes under conditions of clinical isolate-like cell-asso-
ciated growth.
RESULTS
Generation of the wild-type virus Merlin-RL13tetO
and introduction of stop mutations into UL74
Work with clinical HCMV isolates is challenging as their
typical cell-associated phenotype is lost within a few pas-
sages in cell culture (Sinzger et al., 1999). This is due to
mutations in the RL13 gene and the UL128 gene locus,
which allow for cell-free virus transmission and, hence, pro-
vide a selective advantage (Dargan et al., 2010). Attempts to
reconstitute a genetically complete version of the Merlin
strain from a BAC clone regularly resulted in the de-novo
selection of mutations in both RL13 and the UL128 locus
(UL128, UL130 and UL131A). Protection of RL13 and the
UL128 locus against this counterselection could be achieved
by introducing tet operators upstream of each gene locus,
and reconstituting virus in cells that constitutively express
the tet repressor, thereby reducing expression of both gene
loci. In this manner, genetically intact viruses can be gener-
ated (Stanton et al., 2010). The addition of doxycycline
results in sequestration of the repressor, and gene expres-
sion is restored. The virus would then behave like a clinical
isolate, growing in a cell-associated manner for a limited
number of passages.
In the background of this genetically complete Merlin-
RL13tetO-UL128tetO virus, we wanted to analyse the role of
the UL74 reading frame that encodes for gO. However, a
UL74 deletion mutant would be unlikely to be reconstituted
in HFFF-tet cells (where the UL128 locus is repressed),
since dual deletion of trimer and pentamer was lethal in our
previous experiments in the genetic background of strain
TB40/E (Jiang et al., 2008). (Formal proof that dual disrup-
tion of both UL74 and the UL128 locus is actually lethal
also in the Merlin background is provided by the data
shown in Fig. 5.) Therefore, we removed the tet operator
upstream of the UL128 region via markerless mutagenesis
(Tischer et al., 2010), leaving only RL13 regulated by the tet
repressor. When the resulting BAC Merlin-RL13tetO was
transfected into HFFF-tet cells it formed foci of infected
cells and could be grown to 10–20 % cytopathic
effect (CPE) within five passages. To minimize the risk of
mutations in RL13 or the UL128 locus, reconstituted viruses
were only used for focus expansion experiments until 19
days post-transfection. The integrity of these genes was
checked in each experiment by sequencing DNA from
infected cells, and no mutations were found.
In the backbone of our wild-type virus Merlin-RL13tetO, we
knocked out pUL74 by introducing two stop codons at
amino acid positions 16 and 21 via markerless mutagenesis
(Tischer et al., 2010) resulting in BAC Merlin-RL13tetO-
UL74stop (Fig. 1a). This approach was chosen to disrupt
expression of the UL74 gene product gO while minimizing
undesired effects on neighbouring genes. With regard to
UL73, the mutations are not located within the UL73 ORF
but in the intron of primary UL73 transcripts. In contrast
to our previous ATG deletion mutations (Jiang et al., 2008),
the UL74stop mutations would not affect the splice acceptor
site of these pUL73-encoding transcripts (Gatherer et al.,
2011; Scalzo et al., 2009). A BAC, in which these stop muta-
tions were reverted, served as a control for effects caused by
unwanted second site mutations. Both viruses could be
reconstituted by transfection of the respective BAC-DNA
into HFFF-tet cells and propagated by the passaging of the
transfected cell cultures. Aliquots of the infected cultures
were then stored and used for focus expansion assays. Dis-
ruption of protein expression was confirmed by Western
blot analysis (Fig. 1b).
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Minor contribution of pUL74 to focal spread of
the genetically complete HCMV strain Merlin
Freshly reconstituted viruses Merlin-RL13tetO (wild-type),
Merlin-RL13tetO-UL74stop (UL74stop) and Merlin-
RL13tetO-UL74stop-REV (revertant) were analysed by a
co-culture-based focus expansion assay. Briefly, infected
HFFF-tet cells were seeded together with a 100-fold excess
of non-infected indicator cells and co-cultured for 7 days in
the presence of doxycycline. Under these conditions RL13 is
expressed, and as expected no infectious progeny was
detected in the supernatant of these cultures, confirming
the cell-associated phenotype of the RL13-expressing Mer-
lin (Table 1). After 7 days, cultures were fixed, infected cells
were stained by indirect immunofluorescence against viral
IE antigens and the mean number of infected cells/focus
was determined for each virus (Sinzger et al., 1997). The
plaque size of UL74stop (125 cells/focus) appeared reduced
by 15 % when compared with wild-type (143 cells/focus) or
revertant (150 cells/focus) but this reduction did not reach
significance in four independent assays when compared
with the mean values of wild-type and revertant (P=0.069)
(Fig. 2a, c).
To analyse the effects of UL74 in the absence of RL13, rep-
lica cultures were included in each experiment that were
identical except for the omission of doxycycline. In the
absence of doxycycline RL13 is repressed, and this might
allow for release of infectious progeny. If so, based on pre-
vious data with other HCMV strains (Jiang et al., 2008;
Wille et al., 2010), deletion of UL74 should have a signifi-
cant effect on spreading efficiency. However, there was still
no infectious virus detectable in the supernatant, indicating
that repression of RL13 was not sufficient to overcome the
cell association of Merlin-RL13tetO in our culture system.
When UL74 was deleted in the absence of RL13, there was
a 26 % reduction of plaque size (135 cells/focus) when
compared with wild-type (195 cells/focus) or revertant
(170 cells/focus), and this difference just reached signifi-
cance in three independent experiments (P=0.049)
(Fig. 2b, c).
To evaluate the effect of RL13 on focal spread, all three
experiments without doxycycline (RL13-off) and the
respective three matched experiments with doxycycline
(RL13-on) were statistically analysed by a t-test for paired
samples. In this reduced set of RL13-on experiments the
mean focus size of wild-type, UL74stop and revertant was
134, 112 and 143 cells/focus, respectively. In comparison,
under RL13-off conditions the mean focus size (195, 135
and 170 cells/focus, respectively) was increased for each
virus by 44 %, 20 % and 21 %, respectively. Taken together,
the effect of RL13 was highly significant (P=0.003), con-
firming previous reports of the restrictive effect of this gene
on HCMV replication.
To rule out an effect of doxycycline itself on focus size, we
compared focal growth of wild-type virus in primary fibro-
blasts [human foreskin fibroblasts (HFFs)] in the absence or
presence of doxycycline. As these cells do not express the tet
repressor, RL13 is expressed irrespective of doxycycline; and
any effect of doxycycline in this setting would indicate a pro-
prietary effect of this drug on focus size. However, neither
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Fig. 1. Characterization of mutants. (a) Overview of the relevant genomic modifications of the Merlin mutants generated in this
study: all mutants carry the tet operator upstream of RL13. Two consecutive stop codons (**) were introduced into ORFs
UL74, UL128, UL130 and UL131A as indicated in the designation of the respective mutants. (b) Expression of pUL74 and
pUL128 in Merlin mutants. HFFF-tet cells were infected with the respective virus or mock-infected and analysed by immuno-
blotting to test for pUL74 and pUL128 expression. gB signals were used as a loading control. Numbers on the right side indi-
cate the molecular mass. UL, unique long; US, unique short.
Table 1. Detection of cell-free infectious virus (infectious
units ml 1) in the supernatant of infected cultures
Virus Without DOX (RL13
repressed)
With DOX (RL13
expressed)
Wild-type No virus No virus
UL74stop No virus No virus
UL128stop 5.6104 4.6102
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doxycycline itself nor its solvent ethanol had an effect on focus
size in this setting (Fig. S1, available in the online Supplemen-
tary Material).
The fact that detectable levels of cell-free virus were not
found in the supernatant of the respective cultures argued
against a major contribution of cell-free virus. This issue
was further addressed by performing parallel experiments
in the presence of neutralizing anti-HCMV serum to esti-
mate the contribution of cell-free virus transmission. Co-
culture of infected and uninfected cells was performed as
before, except that serum was added at a concentration that
was sufficient to completely neutralize a cell-free prepara-
tion of strain Merlin (Merlin-RL13tetO-UL128tetO produced
on HFFF-tet cells; Fig. S2). The overall plaque size of wild-
type and revertant virus was reduced by <10 % in the pres-
ence of HCMV-seropositive serum (Fig. 3) when compared
with results in the presence of HCMV-seronegative serum
(Fig. 2c), which reached significance only when RL13 was
repressed (P=0.033). Focal growth of UL74stop virus was
not inhibited by HCMV-seropositive serum (P=0.959).
Again, comparison of the three matched experiments
showed an increased plaque size upon repression of RL13
for each of the viruses (by 37 %, 25 % and 32 %,
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Fig. 2. Effect of UL74 disruption on focal spread. Merlin-RL13tetO (wild-type), Merlin-RL13tetO-UL74stop (UL74stop) and
Merlin-RL13tetO-UL74stop-REV (Revertant) were reconstituted by transfection of the respective BAC-DNA into HFFF-tet cells.
Infected HFFF-tet cells were then co-cultured with an excess of uninfected HFFF-tet cells for 7 days with or without doxycy-
cline in the presence of human HCMV-negative serum. Cells were then fixed with 80 % acetone, viral IE-antigens were visual-
ized by indirect immunofluorescence, and the mean number of infected cells per focus was determined. (a, b) Representative
micrographs of foci (a) in the presence of doxycycline, i.e. under conditions of RL13 expression or (b) in the absence of doxy-
cycline, i.e. under conditions of RL13 repression. (c) Graphical representation of focus size (mean±SEM) as determined in 4
(RL13-on) or 3 (RL13-off) independent experiments.
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Fig. 3. Effect of UL74 disruption on focal spread in the presence
of human anti-HCMV serum. Infected HFFF-tet cells were co-cul-
tured with an excess of uninfected HFFF-tet cells for 7 days with
or without doxycycline in the presence of human HCMV-positive
serum at a concentration sufficient to neutralize cell-free virions.
Cells were then fixed with 80 % acetone, viral IE-antigens were
visualized by indirect immunofluorescence and the mean number
of infected cells per focus was determined. Graphical representa-
tion of focus size (mean±SEM) as determined in four (with DOX) or
three (without DOX) independent experiments.
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respectively; P=0.001), providing evidence that RL13
restricts cell-associated growth of strain Merlin in the pres-
ence of HCMV seropositive serum also. While the serum-
sensitive component of focal growth is somewhat suggestive
of cell-free virus transmission even in the absence of detect-
able levels of cell-free infectivity, an alternative effect of the
serum on cell-associated spread cannot be excluded.
To exclude the possibility that a more prominent effect of
UL74 is masked in the immortalized HFFF-tet cells, we
repeated the same experiments in primary fibroblasts and
endothelial cells [human umbilical vein endothelial
cells (HUVECs)]. These cells do not express the tet repres-
sor, and RL13 expression is hence unrestricted. As in HFFF-
tet cells, HCMV-seropositive serum had a moderate inhibi-
tory effect, which was more pronounced in HUVECs (27
%) as compared with HFFs (10 %), but was not significant
in the three independent experiments in either cell type
(P=0.100 and 0.356, respectively) (Fig. 4). Irrespective of
whether HCMV-seropositive or HCMV-seronegative serum
was added, disruption of UL74 had no significant effect on
plaque size in either cell type.
In conclusion, UL74 has only a marginal, if any, effect on
cell-associated growth of a genetically complete HCMV
strain, and focal growth of this virus is mostly resistant to
anti-HCMV serum, particularly in fibroblasts.
Disruption of the UL128 locus reveals the
contribution of pUL74 to cell-free transmission
The lack of a significant contribution of UL74 to growth of
the genetically complete Merlin in fibroblasts and endo-
thelial cells raised doubts as to whether gO expressed by this
strain was functional at all. We hypothesized that a hidden
function of the trimeric gH/gL/gO complex would be
revealed when disruption of the UL128 locus abolished
expression of the pentameric gH/gL/pUL128-131A
complex.
Previous work in the background of the cell-culture adapted
strain TB40/E had shown that the combined disruption of
UL74 and the UL128 locus is lethal, indicating that acces-
sory proteins are essential for the function of gH/gL in the
context of HCMV (Jiang et al., 2008). However, since
a single deletion of UL74 did not substantially alter the
spread of our genetically intact Merlin-BAC derived virus
and a single deletion of UL128 actually enhances virus
spread (Stanton et al., 2010), it was possible that the effect
of simultaneous deletion of both gene regions would differ
in this virus. For example, gH and gL alone might form
functional heterodimers, or even homodimers of two
gH/gL molecules (Fouts et al., 2014). We therefore knocked
out both UL74 and the UL128 locus in the background of
Merlin-RL13tetO.
In the background of Merlin-RL13tetO-UL74stop, two stop
codons were introduced into each of the genes within the
UL128 locus, resulting in mutants Merlin-RL13tetO-
UL74stop-UL128stop, Merlin-RL13tetO-UL74stop-UL130stop
and Merlin-RL13tetO-UL74stop-UL131stop. In addition, a
Merlin-RL13tetO-UL128stop mutant was generated to serve as
a control in which only the pentamer is disrupted but the tri-
mer is intact. Equal amounts of BAC-DNA of the various
mutants were then transfected into HFF cultures, and the
reconstitution of the respective viruses was monitored by
quantitative detection of IE-antigen-positive cells in the trans-
fected cultures for an extended period of 28 days, to detect
growth of the dual mutant in case it occurred with a delay.
The initial transfection rate was similar with all mutants, with
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Fig. 4. Effect of UL74 disruption on focal spread in primary cells. Merlin-RL13tetO (wild-type), Merlin-RL13tetO-UL74stop
(UL74stop) and Merlin-RL13tetO-UL74stop-REV (Revertant) were reconstituted by transfection of the respective BAC-DNA
into HFF cells. Infected HFF cells were co-cultured with an excess of uninfected HFFs (a) or HUVECs (b) for 7 d in the pres-
ence of human HCMV-negative or -positive serum. Cells were then fixed with 80 % acetone, viral IE-antigens were visualized
by indirect immunofluorescence, and the mean number of infected cells per focus was determined. Graphical representation of
focus size (mean±SEM) as determined in three independent experiments.
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about 1 % of cells expressing IE antigen. While the number of
infected cells increased over time with viruses expressing
either the pentamer or the trimer or both, indicating success-
ful replication, the number of infected cells decreased with all
dual mutants, suggestive of abortive infection (Fig. 5a). Ulti-
mately, both Merlin-RL13tetO-UL74stop and Merlin-
RL13tetO-UL128stop formed foci of infected cells, whereas the
dual mutants yielded only single-standing infected cells that
expressed IE antigens and late antigens but could not spread
the infection, indicated by lack of IE antigens in neighbouring
cells (Fig. 5b). The revertant virus generated on the basis of
Merlin-RL13tetO-UL74stop-UL128stop grew like the parental
Merlin-RL13tetO, ruling out the possibility that the non-viable
phenotype of the dual mutants was due to unwanted second
site mutations (data not shown). Thus, as in TB40/E, dual dis-
ruption of UL74 and the UL128 locus is lethal in Merlin.
The UL74stop mutant showed a small reduction regarding
viral growth during the reconstitution period when com-
pared with wild-type virus (Fig. 5a), which was consistent
with the minor contribution of UL74 to focal growth seen
in the previous section. Remarkably, the UL128stop mutant
grew faster than wild-type virus, and this superiority of the
UL128stop mutant over wild-type virus was addressed in a
final set of experiments.
The fact that Merlin-RL13tetO-UL74stop-UL128stop could
not be reconstituted indicated that the viral spread
depended totally on the expression of either the pentamer
or trimer. Hence, the extent and mode of virus transmission
of the UL128stop mutant can be unequivocally attributed to
expression of UL74. Previous reports suggested that UL74 is
critical for cell-free virus transmission. To test whether
UL74 also mediates cell-free transmission in the back-
ground of strain Merlin, the UL128stop virus was compared
to wild-type virus with and without RL13 expression
regarding focus size in the absence or presence of anti-
HCMV serum. Serum-resistant growth is assumed to reflect
cell-associated spread, whereas serum sensitive growth is
assumed to reflect cell-free transmission. The UL128stop
mutant grew with increased plaque size as compared with
wild-type, and this gain of spreading capacity was greatly
enhanced when RL13 was downregulated (Fig. 6a).
The spread of the mutant was predominantly serum-sensi-
tive, indicating cell-free transmission via the trimer (Fig. 6b
vs Fig. 6a); however, a serum-resistant residual focus
remained, indicative of cell-associated spread. This result
was corroborated in an additional experiment comparing
the effects of HCMV-positive serum and a neutralizing
monoclonal anti-gB antibody on focal spread of the
UL128stop mutant, both showing the same degree of inhib-
ition (Fig. S3). The appearance of a comet shape under con-
ditions of RL13 downregulation supported the idea that a
large part of the trimer-mediated growth was due to cell-
free virus transmission (Fig. 6c). Consistent with this
assumption, this comet-shaped spread was mostly neutral-
ized by anti-HCMV serum. Finally, the question of whether
Merlin-RL13tetO-UL128stop releases infectious progeny was
directly addressed by the analysis of supernatants from
infected cultures. Cell-free infectivity was found with
Merlin-RL13tetO-UL128stop, with the amount of infectivity
depending on RL13 repression (Table 1). Thus when RL13
was expressed (in the presence of doxycycline), titres were
100-fold lower as compared with titres in the presence of
RL13 (i.e. in the absence of doxycycline). Taken together,
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Fig. 5. Phenotype of dual disruption of UL74 and the UL128 locus. (a) Human foreskin fibroblasts (HFFs) were transfected
with equal amounts of DNA from wild-type, single or dual stop mutants. At indicated time points post-transfection, aliquots of
the cultures were stained for viral immediate early (IE) antigens. The percentage of IE antigen-positive cells is plotted against
time post-transfection. Only wild-type viruses and single mutants could grow and increase the number of IE antigen-positive
cells over time, whereas none of the dual mutants could grow despite initial transfection rates being comparable to that of the
single mutants. Data represent mean values of at least three repeated experiments for wild-type viruses, UL74stop mutant and
UL128stop mutant. Data of the dual stop mutants are mean values from two independent clones for each mutant. (b) Immuno-
fluorescence stainings of HFF cultures 7 days after transfection with the respective Merlin-BAC. Cells were fixed with acetone
and stained by indirect immunofluorescence for IE antigens (red) and the late tegument protein pp150 (green).
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these findings indicate that the trimer can drive both cell-
associated (serum-resistant) and cell-free transmission
(serum-sensitive) with RL13 being an effective restriction
factor of cell-free UL74-driven spread (also see Fig. 6c).
DISCUSSION
One major conclusion from our results is that disruption of
UL74 has little, if any, effect on focal cell-associated spread
of the genetically complete variant of HCMV strain Merlin,
in either fibroblasts or endothelial cells. There was a slight
reduction by some 15 %; however, this was not highly sig-
nificant in a set of four experiments. This contrasts with the
well-documented small plaque phenotype that is caused by
disruption of UL74 in the background of various cell
culture-adapted HCMV strains (i.e. strains that can form
large comet-shaped foci via cell-free virus) including
AD169, Towne, TR and TB40-BAC4 (Dunn et al., 2003;
Hobom et al., 2000; Jiang et al., 2008; Wille et al., 2010; Yu
et al., 2003). In these strains, the small plaque phenotype
can be explained by an almost complete loss of cell-free
spread of viral progeny (Jiang et al., 2008; Wille et al.,
2010). Thus it may be that loss of pUL74 failed to have a
similar effect on focus size in the context of Merlin since
(like clinical isolates) Merlin does not produce large
amounts of cell-free virus in culture (Dargan et al., 2010;
Stanton et al., 2010).
We can exclude the possibility that the UL74 gene product
is non-functional in our wild-type virus Merlin-RL13tetO as
its contribution was revealed in the absence of expression
from the UL128 locus. Thus it appears that both UL74 and
the UL128 locus can mediate viral spread, though via differ-
ent mechanisms. The spread driven by the UL128 locus,
probably via the pentameric gH/gL complex, appears cell-
associated and almost completely resistant to neutralizing
anti-HCMV serum, whereas the spread driven only by the
trimer has a cell-free component as indicated by its suscep-
tibility to neutralizing anti-HCMV serum and the detection
of infectious progeny in the supernatant.
Regarding the specific contributions of the trimer and pen-
tamer in the virion envelope, it seems that levels of one
complex are always formed at the expense of the other,
since both gO and UL128 bind to the same cysteine on gL
(Ciferri et al., 2015; Zhou et al., 2015). Thus in the genetic-
ally intact Merlin, levels of pentamer are high, but trimer is
low, and loss of gO has little effect. Under these circumstan-
ces, the spread is pentamer-driven and is almost exclusively
cell-associated. In strains that have been passaged, genetic
changes result in increased levels of the trimer, but reduced
levels of pentamer (Murrell et al., 2013; Zhou et al.,
2013, 2015). When this occurs, cell-free infectivity appears,
and this transmission mode depends on UL74. Consistent
with our previous findings in the TB40/E background (Jiang
et al., 2008), gH and gL alone were not sufficient for virus
spread in the context of Merlin, arguing against a role for
gH-gL dimers in the spread, at least in the cell types tested
here.
While pentamer-mediated spread is clearly almost exclusively
cell-associated, the situation is not as unequivocal with the tri-
mer. There is certainly a strong cell-free component as proven
by the detection of infectivity in the supernatant of mutant
Merlin-RL13tetO-UL128stop and the inhibitory effect of anti-
HCMV serum on the plaque size of this virus. However, there
is also substantial spread in the presence of the neutralizing
serum indicating that there is also a cell-associated
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Fig. 6. Effect of UL128 disruption on focal spread. Infected HFFF-tet cells were co-cultured with an excess of uninfected
HFFF-tet cells for 7 days with (RL13-on) or without (RL13-off) doxycycline in the presence of human HCMV-negative (a) or
HCMV-positive (b) serum. Cells were then fixed with 80 % acetone, viral IE-antigens were visualized by indirect immunofluo-
rescence, and the mean number of infected cells per focus was determined. Graphs represent the focus size (mean±SEM) as
determined in three independent experiments. (c) Representative micrographs showing focal growth of wild-type virus (Merlin-
RL13tetO) and the UL128stop mutant under various conditions.
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component. Fitting with this interpretation, the serum-resis-
tant component of plaques mediated by the trimer have a
similar size as the pentamer-driven cell-associated plaques.
While this study was primarily focussed on the role of gO in
the context of a genetically complete HCMV strain, it also
confirms the restrictive effects of RL13 on viral spread. The
plaque size of all tested viruses was increased when RL13 was
repressed, fitting in with the reported function of RL13 as an
inhibitor of virus spread (Stanton et al., 2010). When the
pentamer was disrupted by stop mutations in the UL128
locus, cell-free virus transmission occurred, and in this situ-
ation RL13 greatly restricted the amount of cell-free infectiv-
ity, fitting in with previous reports on the effects of RL13
mutations on virus titres (Dargan et al., 2010; Stanton et al.,
2010). It is remarkable that HCMV encodes two factors that
can restrict cell-free virus transmission, RL13 and the UL128
region. As a consequence, effective cell-free spread only
occurs when both gene regions are downmodulated.
It is an unusual situation that of the three gene regions
addressed in this study, RL13 and UL128 restrict viral repli-
cation and UL74 is dispensable when the other two are
expressed, but none clearly increases replication in the con-
text of a genetically complete HCMV. This raises several
questions: Why are these genes conserved among HCMV
isolates, i.e. what is their function during the natural course
of infection in the host? Are there certain cell types or tis-
sues in which they promote viral replication? Is their
replication-promoting effect only revealed in the presence
of an antiviral immune response? The mutants created on
the basis of the genetically complete Merlin-BAC can now
be applied to address these questions.
Considering our data in the context of existing literature
on gO, it is tempting to speculate about the possible role
of the trimeric gH/gL complex during natural infection.
Homologues of gO are conserved among beta herpesvi-
ruses, indicating that it performs a crucial function. Con-
sidering only HCMV strains, there is a remarkable degree
of polymorphism, suggesting a selective pressure on this
protein (Mattick et al., 2004; Paterson et al., 2002; Ras-
mussen et al., 2002; Stanton et al., 2005). Taken together,
it appears unlikely that gO is dispensable in vivo. Rather,
the retention of UL74 by the virus suggests that cell-free
virus is important for the biology of the virus. A hint at a
possible function comes from recent work with murine
cytomegalovirus (MCMV), where gH/gL also forms a tri-
mer with gO and an alternative complex with MCK-2
(encoded by m131–129). In an in vivo model both the
efficiency of initial inoculation of mice with cell-free virus
(intraperitoneally or intravenously) and subsequent spread
within various organs were evaluated (Lemmermann,
et al., 2015). In this model, gO was necessary for cell-free
infection of a new host, but dispensable for spread within
organ tissues. It is tempting to assume a similar function
of gO for HCMV: the trimeric complex would then be
essential for cell-free host-to-host spread, e.g. by breast
milk, saliva or urine, whereas cell-associated dissemination
within the infected host would be primarily driven by the
pentameric complex. In this context it is noteworthy that
cell-free infectious HCMV can be found in the milk whey
of lactating women and in the urine of infected children
(Hamprecht et al., 2003; Stagno et al., 1975), but once
they are isolated and propagated in fibroblast cultures
HCMV strains are cell-associated (Sinzger et al., 1999;
Yamane et al., 1983). Speculating about possible sources
for the cell-free infectivity in urine and milk whey, epithe-
lial cells in the kidney and the breast are among the
primary candidates. Interestingly, cell type differences
regarding virus release and virion composition have been
reported previously (Scrivano et al., 2011; Wang et al.,
2007), suggesting that the search for a cell type that would
transmit the genetically complete Merlin in a cell-free
mode, dependent on gO, is a realistic target.
METHODS
Cells and viruses. HFFF-tet cells (Stanton et al., 2010) and primary
human foreskin fibroblasts (HFF) were cultured in minimum essential
medium (MEM) supplemented with GlutaMAX (Life Technologies),
5% FCS, 0.5 ngml 1 basic fibroblast growth factor (bFGF, Life Tech-
nologies), and 100 µg ml 1 gentamicin. Experiments were carried out in
the absence of bFGF to exclude the possibility of interference of this
growth factor with virus transmission. Human umbilical vein endothe-
lial cells (HUVECs) were always seeded onto gelatin-coated vessels and
maintained in RPMI1640 medium (Life Technologies) supplemented
with 10% HCMV-seronegative human serum, 50µgml 1 endothelial
cell growth supplement (ECGS, BD Biosciences), 5 unitsml 1 heparin
(Sigma-Aldrich) and 100 µgml 1 gentamicin.
A Merlin-BAC clone containing the complete wild-type HCMV
strain Merlin genome, with tet-operators inserted upstream of
UL131A and RL13 (Merlin-RL13tetO-UL128tetO; pAL1502) (Stanton
et al., 2010) was used as the parental BAC in this study. Merlin-
BAC and derived mutants were reconstituted in HFF or HFFF-tet
cells by calcium phosphate transfection (MBS transfection kit, Agi-
lent) or lipofection (K2 Transfection System, Biontex) and further
propagated in the absence of bFGF. Infected cells were cultured up
to 19 days post-transfection and frozen into aliquots. In parallel, a
small portion of the culture was adhered to gelatin-coated 96-well
plates and subjected to the determination of the infection rate by
immediate early (IE) antigen staining.
Generation of mutants. Mutant BACs were generated by applying
the markerless mutagenesis protocol of Tischer et al. (2010). In brief,
Merlin-BAC-DNA was retransformed into the Escherichia coli strain
GS1783 by electroporation, and the integrity of the genome was con-
firmed by restriction fragment length analysis (RFLA). To generate
mutants, recombination fragments were generated by PCR from plas-
mid pEP-Kan-S with primers as shown in Table 2. The resulting frag-
ments consisted of the 18-bp I-Sce I restriction site and a kanamycin
resistance cassette flanked by repeated sequences containing homology
to the desired site of insertion in the HCMV genome. The recombina-
tion fragments were inserted into the recombination-activated GS1783
harbouring the Merlin-BAC by electroporation. Following kanamycin
selection, all non-HCMV sequences were removed by an intrabacterial
I-Sce I digest and a subsequent red recombination step. BAC-DNA was
isolated using the NucleoBond Xtra Midi kit (Macherey-Nagel), and
each mutant was analysed by RFLA and sequencing.
Immunofluorescence. For detection of viral IE antigen (pUL122/
123), cells were fixed with 80 % acetone and incubated sequentially with
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primary antibody E13 (Argene) and secondary antibody Cy3-goat anti-
mouse IgG F(ab¢)2 (Jackson ImmunoResearch). Additional detection of
viral pUL32 was achieved by incubation with primary antibody MAb
36–14 (a generous gift from W.J. Britt, University of Alabama, Birming-
ham) (Sanchez et al., 2000) and secondary antibody Alexa Fluor488-
conjugated goat anti-mouse IgG F(ab¢)2 (Invitrogen). Counterstaining
of nuclei was performed with DAPI.
Focus expansion assays. Viral spread was tested by a focus expan-
sion assay essentially as previously described (Sinzger et al., 1997). Ali-
quots of infected cell cultures (HFFs or HFFF-tet cells with about 10 %
CPE) were thawed, washed once with MEM and co-cultured with a
100-fold excess of uninfected indicator cells (HFFs, HFFF-tet cells or
HUVECs) for 7 days in gelatin-coated 96-well plates in the presence of
2 % native human HCMV-negative or positive serum. In the case of
HFFF-tet cells, infected cells and indicator cells were pretreated with
2 µg ml 1 doxycycline or its solvent ethanol for a minimum of 3 days
prior to co-culture and maintained under treatment until termination of
the experiment. At day three post-seeding, half of the supernatant was
exchanged with freshly prepared medium containing doxycycline or eth-
anol together with the respective human seronegative or seropositive
serum. Plates were fixed and stained for IE antigen and DAPI as
described above. The average number of infected cells per focus was
quantified. All experiments were controlled for the absence of unwanted
mutations in relevant genes (RL13, UL74, UL128, UL130, UL131A) by
PCR amplification followed by sequencing of DNA either from frozen
aliquots used for co-culture or from stained cell cultures at the end of
focus expansion assays.
Detection of cell-free infectivity. Supernatants from focal expansion
assays treated with human HCMV-negative serum were harvested prior
to termination of the experiment from four individual wells, pooled and
centrifuged at 3220 g for 10 min to remove cellular debris. HFF indica-
tor cells in gelatin-coated 96-well plates were infected with serial dilu-
tions of the respective freshly prepared supernatants in duplicate and
incubated for 24 h. Cells were fixed, stained for viral IE antigen as
described above and viral titres were calculated as infectious units ml 1.
Western blot analysis. Aliquots of infected HFFF-tet cells were
thawed, washed once with MEM and co-cultured with uninfected
HFFF-tet cells in six-well plates for 7 days. Cells were scraped from the
plates, pelleted and washed twice with PBS. Cell lysis was performed on
ice in a buffer containing 2 % sodium dodecylsulfate, 62.5 mM Tris (pH
6.8), 10 % glycine and 0.01 % bromphenol blue. After addition of 10 %
Table 2. Mutants used in this study
Mutant BAC Genotype Primer sequences*
Merlin-RL13tetO Wild-type GCCGCATGTTGCAGACTGAGAAAGAAAGCTTTATTATGAGACATCATACACATAGTA
TAGaggatgacgacgataagt
TCCCCGCCCCATCACCTCGCCTATACTATGTGTATGATGTCTCATAATAAAGCTTTC
TTTcaaccaattaaccaattctga
Merlin-RL13tetO-UL74stop UL74stop AAAAAAGAGATGATAATGGTGAAAGGCATTCCTAAAATTTAA
CTCCTGATCTCTTGAACGTTCTTGCTCCTTTCCCTaggatgacgacgataagt
CCAATACATTACAATTTATGAGGGAAAGGAGCAAGAACGTTCAAGAGATCAGGAG
TTAAATTTTAGGAATGCCTTTCAcaaccaattaaccaattctga
Merlin-RL13tetO-UL128stop UL128stop ACGGCTGAGATTCGCGGGATCGTCACCACCATGACCTAGTCATTGACATGACAGGTCG
TACACAACAaggatgacgacgataagt
GTAGTTGCAGCTCGTCAGTTTGTTGTGTACGACCTGTCATGTCAATGACTAGGTCA
TGGTGGTGACGcaaccaattaaccaattctga
Merlin-RL13tetO-UL74stop-
UL128stop
UL74stop-
UL128stop
ACGGCTGAGATTCGCGGGATCGTCACCACCATGACCTAGTCATTGACATGACAGGTCG
TACACAACAaggatgacgacgataagt
GTAGTTGCAGCTCGTCAGTTTGTTGTGTACGACCTGTCATGTCAATGACTAGGTCA
TGGTGGTGACGcaaccaattaaccaattctga
Merlin-RL13tetO-UL74stop-
UL130stop
UL74stop-
UL130stop
CTGCCTGCTTCTGTGCGCGGTTTGGGCAACGCCCTGTCTG
TAGTCTCCGTGGTCGTAACTAACAGCAAACCAGAATCCaggatgacgacgataagt
GTTTAGACCATGGCGGGGACGGATTCTGGTTTGCTGTTAG
TTACGACCACGGAGACTACAGACAGGGCGTTGCCCAAAcaaccaattaaccaattctgaPlos
Merlin-RL13tetO-UL74stop-
UL131stop
UL74stop-
UL131stop
GTCTGTTTGTCTGTGCGCCGTGGTGCTGGGTCAGTGCCAG
TAGGAAACCGCGGAATAAAACGATTATTACCGAGTACCaggatgacgacgataagt
AGCACGCGTCCCAGTAATGCGGTACTCGGTAATAATCGTTTTATTCCGCGGTTTCC
TACTGGCACTGACCCAGCACCAcaaccaattaaccaattctga
Merlin-RL13tetO-
UL74stopREV-
UL128stopREV
Revertant AAAAAAGAGATGATAATGGTGAAAGGCATTCCTAAAATTATGCTCCTGATCTCTA
TAACGTTCTTGCTCCTTTCCCTaggatgacgacgataagt
CCAATACATTACAATTTATGAGGGAAAGGAGCAAGAACGTTATAGAGATCAGGAGCA
TAATTTTAGGAATGCCTTTCAcaaccaattaaccaattctga
ACGGCTGAGATTCGCGGGATCGTCACCACCATGACCCATTCATTGACACGCCAGGTCG
TACACAACAaggatgacgacgataagt
GTAGTTGCAGCTCGTCAGTTTGTTGTGTACGACCTGGCGTGTCAATGAATGGGTCA
TGGTGGTGACGcaaccaattaaccaattctga
*Uppercase letters, HCMV homology; lowercase letters, homology to template plasmid pEP-Kan-S; bold letters, sequence of interest.
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2-mercaptoethanol, proteins were separated in 10 % polyacrylamide gels
and transferred to polyvinylidene fluoride membranes (Millipore) in
Tris-Glycine buffer (containing 38 mM Tris, 288 mM glycine and 15 %
methanol). Membranes were blocked with PBS plus 0.1 % Tween and
5 % milk powder. Gel loads were adjusted to gB signals (mouse mono-
clonal anti-cytomegalovirus glycoprotein B antibody, abcam). The
mouse monoclonal anti-pUL128 was a generous gift from Giuseppe
Gerna (Pavia, Italy) (Gerna et al., 2008). Anti-gO mouse mAb was gen-
erated by immunizing BALB/c mice with gO/human IgG1Fc fusion pro-
tein purified by protein A affinity chromatography from supernatants of
transfected HEK293T cells as described previously (Jager et al., 2013).
Stable hybridoma cell lines were generated by fusing SP2/0 myeloma
cells with spleen cells of an immunized mouse. The antibody was puri-
fied by protein G affinity chromatography using an ÄKTAprime plus
system (GE Healthcare). HRP conjugated secondary antibodies were
purchased from Santa Cruz. For detection, membranes were incubated
with luminol (Super Signal West Dura chemiluminescence kit, Pierce)
and signals were visualized in a chemiluminescence reader (Fusion SL,
Peqlab).
Statistical analyses. Differences between paired data sets from 3–4
independent experiments were analysed for statistical significance with
two-tailed t-tests for paired samples using the built-in data analyses
function of Excel. Data shown in Figs 2(c) and 3 originate from the
same set of experiments and could, hence, also be analysed in a pairwise
fashion.
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